Kidsafe NSW promotes child injury prevention and education in an effort to preserve and protect the lives of our children.

Aspen Pharmacare Australia Pty Ltd — Span-K (potassium chloride) 600mg tablets

1 May 2017

A cap that is not child-resistant will make access to the tablets easier for children. Ingestion of unprescribed potassium chloride could be harmful.

What are the defects?

This is a recall for correction of the packaging only. The bottles have been supplied with a cap that is not child-resistant.
There is no concern regarding the quality or safety of this medicine.

What are the hazards?

A cap that is not child-resistant will make access to the tablets easier for children. Ingestion of unprescribed potassium chloride could be harmful.

What should consumers do?

If you or someone you care for is taking Span-K 600mg tablets, please return the medicine to a pharmacy so that the cap can be replaced with one that is child-resistant.

In the meantime, keep taking your medicine as prescribed.

Medicine should always be kept out of reach of children, as stated on the product packaging.

If you have any questions or concerns about this issue, contact your health professional or Aspen Pharmacare on 1300 659 646 (option2).

Supplier
Aspen Pharmacare Australia Pty Ltd
Traders who sold this product

Pharmacies nationally

Where the product was sold
Nationally

Responsible regulator

Therapeutic Goods Administration (link is external) is the responsible regulator for this recall.

Product category
 
Content source:  Product Safety Australia